Umbrella Study for Single Patient Treatments in Oncology
The purpose of this study is to collect data on how advanced and rare cancers respond to biomarker-based treatments.
- EligibilityCriteria: Inclusion Criteria & Exclusion Criteria:  Patient's existing genomic information from tumor molecular profiling will be discussed in the hospital expert molecular tumor board rounds consisting of representatives from specialist genomic profiling and medical oncology departments to decide N of 1 treatment for the patient. The discussion will surround the best next therapeutic option in the patient's cancer subtype with or without clear standard of care guidelines. Therefore, specific eligibility criteria aside from individual patient's medical history is not applicable. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Patients have advanced and rare cancer with limited treatment options. - SamplingMethod: Non-Probability Sample